ALZHEIMER’S DISEASE: PROBLEM SOLVING FOR UNINTERRUPTED TRIAL PROGRESS INTERNATIONAL: +44 (0) 20 7121 6161 | AMERICAS: +1 610 964 2000 | WORLDWIDE.COM CASE STUDY DESCRIPTION Worldwide Clinical Trials was retained to intervene in a Phase IIb, multinational, randomized, double-blind, placebo-controlled study in subjects with progressive cognitive decline compatible with the diagnosis of prodromal Alzheimer’s disease (AD). CHALLENGE • The original CRO had failed to meet enrollment expectations due to inadequate vetting of site capabilities for this unique diagnostic category, which required the use of multiple sophisticated screening assessments that served as a “gatekeepers” for patient eligibility. • The study had been launched in over 30 centers by the sponsor wit

Join for free to read